Vasomune Therapeutics, Inc. logo

Vasomune Therapeutics, Inc.

Vasomune Therapeutics is a biotechnology company developing compounds targeting diseases associated with vascular dysfunction and destabilization. The company’s lead compound is Vasculotide, a Tie2 receptor agonist that is being developed to treat acute lung injury (ALI) and acute kidney injury (AKI).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.vasomune.com
Disease Focus
STOCK CODENon Listed
Address
661 University Ave, Ontario, M5G 1M1
Toronto
Canada
Email
Contact Number
+1 416-697-0289

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]